Neem and blood sugar

What 2 graded rows on neem agree on for blood sugar, and where they differ. Counted side by side, never averaged.

Consensus finder Rows from the Neem page, reviewed Oct 21, 2026 How it decides

What the rows agree on

Each block and row is one graded row from the Neem page, with its PubMed record.

Supplement

Neem Choose another

2 rows · 106 people

They agree: both rows found an improvement.

No difference

Improved

Each block is one evidence row, sized by how many people it enrolled, with its grade inside.

From the rows

The best-graded row, grade D, is a randomized trial of 80 people (2021) and found an improvement.

The rows run from 26 to 80 people, published from 2006 to 2021: 2 single studies.

2 improved

Grade DGlucose, insulin resistance and endothelial function in metabolic syndrome · Improved
RCT · n 80 · 2021 · Adults with metabolic syndrome (India)
125, 250 or 500 mg twice daily (250–1,000 mg/day) · 12 weeks
Fasting and post-meal glucose, insulin resistance, HbA1c, endothelial function and most inflammation and oxidative-stress markers improved dose-dependently vs placebo.
Row on the Neem page · PubMed 34582720 (opens PubMed)
Grade DFasting blood glucose in type 2 diabetes · Improved
Open-label trial · n 26 · 2006 · Adults with type 2 diabetes, untreated or on oral glucose-lowering drugs, plus 6 control subjects (Pakistan)
0.5 g or 2 g three times daily · 14 days
The high dose had a significant glucose-lowering effect, including in patients already on oral glucose-lowering drugs.
Row on the Neem page · PubMed 17105712 (opens PubMed)